You are here: Industry Insights > Johnson & Johnson

News List

EU signs contract with J&J on Covid-19 vaccine candidate pharmaceutical-technology
October 23, 2020
The European Commission (EC) has signed a contract on behalf of European Union (EU) states with Johnson & Johnson (J&J) for the supply of 400 million doses of its Covid-19 vaccine candidate.
Financial Report; Johnson & Johnson contractpharma
October 19, 2020
Pharmaceutical sales were up 5% in the quarter to $11.4 billion.
J&J COVID-19 vaccine trial paused due to unexplained illness in participant expresspharma
October 15, 2020
The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the company's clinical and safety physicians, informed J&J.
CDMO to conduct fill and finish manufacture of COVID-19 vaccine europeanpharmaceuticalreview
October 09, 2020
US outsourcing organisation GRAM is set to undertake the aseptic fill and finish manufacture of J&J’s COVID-19 vaccine candidate.
GRAM, J&J Enter COVID-19 Vax Manufacturing Pact contractpharma
September 27, 2020
GRAM to provide advanced aseptic fill and finish services for supply of J&J’s SARS-CoV-2 vaccine candidate from its facility in Grand Rapids, MI.
J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax contractpharma
September 24, 2020
Will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose of JNJ-78436735 versus placebo.
Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies drugs.com
September 24, 2020
Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters, upon challenge with SARS-CoV-2, the virus that causes COVID-19 in people.
J&J faces $2bn insurance fraud charges over opioid claims pharmaceutical-technology
September 21, 2020
The New York State Department of Financial Services (DFS) has filed a $2bn lawsuit against Johnson & Johnson (J&J) for its alleged role in the opioid crisis in the US.
Three major deals contributed 74 per cent of deal value in August 2020 expresspharma
September 07, 2020
In August 2020, the healthcare industry reported 59 deals worth $35.4 billion as compared to the last 12-month average (August 2019 to July 2020) of 73 deals worth $10 billion.
COVID-19 vaccine makers to prepare joint pledge for safety expresspharma
September 07, 2020
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page